Kineta Inc. (NASDAQ: KA)
$0.71
-0.0190 ( -2.60% ) 109.5K
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.
Market Data
Open
$0.71
Previous close
$0.73
Volume
109.5K
Market cap
$8.70M
Day range
$0.71 - $0.79
52 week range
$0.33 - $5.39
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Sep 15, 2023 |
| 8-k | 8K-related | 14 | Aug 31, 2023 |
| 8-k | 8K-related | 12 | Aug 16, 2023 |
| 8-k | 8K-related | 45 | Aug 11, 2023 |
| 10-q | Quarterly Reports | 86 | Aug 11, 2023 |
| 8-k | 8K-related | 14 | Aug 11, 2023 |
| 8-k | 8K-related | 13 | Jul 21, 2023 |
| 3 | Insider transactions | 2 | Jul 05, 2023 |
| 3 | Insider transactions | 2 | Jul 05, 2023 |
| 4 | Insider transactions | 1 | Jul 05, 2023 |